Introduction: When to Seek Diagnosis

If you notice any unusual changes in your body, it’s important to pay attention. A neoplasm, which is simply another word for tumor, refers to any abnormal growth of tissue that forms when cells multiply more than they should. Not all neoplasms are dangerous—many are benign, meaning they’re not cancerous and won’t spread to other parts of your body. However, some are malignant, which means they are cancerous and can invade nearby tissues or travel to distant organs.^[1]

You should consider seeking medical evaluation if you notice a lump or bump that doesn’t go away, especially if it feels firm and doesn’t move easily under your skin. Other warning signs include unexplained weight loss, persistent fatigue, night sweats that soak your sheets, fever without an obvious cause, or changes in your bowel or bladder habits. If you develop sores on your skin that don’t heal, notice unusual bleeding or discharge, or experience pain that doesn’t improve, these are all reasons to contact your healthcare provider.^[1][5]

The location of the neoplasm often determines what symptoms you’ll experience. For example, someone with a growth in their breast might notice a lump or abnormal nipple discharge. A person with a tumor in their colon might have abdominal pain or see changes in their stool. Skin neoplasms might appear as unusual sores or lesions. Because symptoms vary so widely depending on where the growth is located and whether it’s cancerous, it’s essential to have any concerning changes checked by a doctor.^[1]

People over 65 are more likely to develop malignant neoplasms, though these growths can occur at any age. If you have a family history of cancer, inherited genetic conditions like Lynch syndrome (a condition that increases cancer risk due to inherited gene changes), or exposure to risk factors like tobacco smoke or radiation, you may benefit from more regular screenings even without symptoms.^[1][5]

Diagnostic Methods for Neoplasms

When you visit your doctor with concerns about a possible neoplasm, they will typically start with a thorough physical examination. During this exam, your doctor will ask about your symptoms, medical history, family history of cancer, and any risk factors you might have. They’ll examine any lumps or areas of concern by looking at them and feeling them to assess size, texture, and whether they move under the skin.^[6]

Imaging Tests

If your doctor suspects a neoplasm, the next step usually involves imaging tests. These tests allow doctors to see inside your body without surgery. Imaging is crucial because many tumors develop in places you can’t see or feel from the outside, such as inside organs, bones, or deep tissues.^[6][12]

Ultrasound uses sound waves to create pictures of the inside of your body. It’s often used to examine lumps in soft tissues, such as breast lumps or pelvic masses. A device called a transducer is moved over your skin, sending sound waves that bounce back to create images on a screen. This test is painless and doesn’t use radiation.^[6]

Mammography is a specialized X-ray of the breast tissue used to detect breast neoplasms. It can find lumps that are too small to feel and is an important screening tool for early detection of breast cancer. During a mammogram, your breast is briefly compressed between two plates while X-ray images are taken.^[6]

Computed tomography (CT) scans use X-rays taken from many angles and computer processing to create detailed cross-sectional images of your body. CT scans can show tumors in organs, bones, and soft tissues with much greater detail than regular X-rays. You may be asked to drink a contrast liquid or have contrast dye injected into a vein to help certain areas show up more clearly.^[6]

Magnetic resonance imaging (MRI) uses powerful magnets and radio waves to create detailed images of soft tissues in your body. MRI is particularly good at showing the difference between normal and abnormal tissue and is often used to examine the brain, spinal cord, and soft tissues like muscles and ligaments. Unlike CT scans, MRI doesn’t use radiation.^[6]

Positron emission tomography (PET) scans involve injecting a small amount of radioactive sugar into your bloodstream. Cancer cells, which tend to be more active than normal cells, absorb more of this sugar and show up as bright spots on the scan. PET scans are often combined with CT scans to provide both functional and structural information about tumors.^[6]

Endoscopy involves inserting a thin, flexible tube with a light and camera on the end into your body through a natural opening or small incision. Different types of endoscopy examine different areas. For example, a colonoscopy looks at the inside of your colon and rectum, while an upper endoscopy examines your esophagus, stomach, and the first part of your small intestine. During these procedures, doctors can see abnormal growths directly and take tissue samples if needed.^[6]

Biopsy: The Definitive Test

While imaging tests can show where a tumor is located and how large it is, the only way to definitively determine whether a neoplasm is benign, precancerous, or malignant is through a biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor so it can be examined under a microscope by a specialist called a pathologist.^[6][12]

There are several types of biopsies, and the method used depends on where the tumor is located. A fine needle aspiration uses a very thin needle to remove a small amount of tissue or fluid. A core needle biopsy uses a larger needle to remove a slightly bigger tissue sample. An excisional biopsy removes the entire lump or suspicious area, while an incisional biopsy removes only part of it. Some biopsies can be done in a doctor’s office with local numbing medicine, while others may require sedation or general anesthesia.^[6]

When the pathologist examines the biopsy sample, they look at the cells’ appearance and arrangement. Cells in benign tumors typically look relatively normal and are well-organized. In contrast, cells in malignant tumors show multiple abnormalities in their structure and are often disorganized. The pathologist can also identify specific markers on the cells that help determine what type of cancer it is and how aggressive it might be.^[6][12]

Blood Tests and Laboratory Work

Blood tests don’t usually diagnose neoplasms directly, but they provide important supporting information. Certain blood tests can detect tumor markers—substances produced by cancer cells or by your body in response to cancer. For example, the prostate-specific antigen (PSA) test measures a protein that may be elevated in prostate cancer. However, tumor markers alone aren’t enough to diagnose cancer because they can be elevated for other reasons too.^[6]

Complete blood counts can reveal abnormalities that suggest cancer, such as unusual numbers of blood cells in leukemia. Other blood tests check your liver and kidney function, which helps doctors understand your overall health and plan treatment if cancer is found.^[1]

Distinguishing Benign from Malignant Neoplasms

One of the primary goals of diagnostic testing is to determine whether a neoplasm is benign or malignant, because this fundamentally changes treatment approaches. Benign tumors grow slowly, stay in one place, and have well-defined borders that make them easy to remove surgically if necessary. They don’t invade surrounding tissues or spread to distant parts of the body, and they rarely come back after removal.^[5][8]

Malignant tumors, on the other hand, grow more rapidly and have irregular borders. They invade nearby tissues and can break away from the original tumor to travel through your bloodstream or lymphatic system (a network of vessels that carry fluid and immune cells throughout your body). This spreading process is called metastasis. When cancer cells travel to new locations, they can form secondary tumors far from where the cancer started.^[1][12]

Sometimes doctors identify precancerous or premalignant lesions—abnormal cell growths that aren’t yet cancer but have the potential to become malignant over time. Terms like hyperplasia (cells dividing rapidly) or dysplasia (abnormal cells dividing rapidly) describe these changes. Finding and treating precancerous lesions can prevent cancer from developing. For example, removing colon polyps during a colonoscopy or treating cervical dysplasia can stop these conditions from progressing to cancer.^[5][8][7]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial to test new treatments for cancer, you’ll need to undergo specific diagnostic tests to determine whether you qualify. Clinical trials have strict enrollment criteria to ensure the safety of participants and the validity of the research results. These criteria, called inclusion and exclusion criteria, help researchers select patients who are most likely to benefit from the experimental treatment.^[1]

Before enrolling in a trial, you’ll typically need comprehensive diagnostic testing to confirm your cancer type, stage, and other characteristics. A biopsy is almost always required to verify the exact type of cancer and sometimes to test for specific genetic mutations or protein markers that the trial is targeting. For example, some breast cancer trials only accept patients whose tumors have certain receptors, such as HER2 protein, which can be detected through special laboratory tests on biopsy samples.^[1]

Imaging tests like CT scans, MRI, or PET scans are used to determine the size of the tumor and whether cancer has spread to other parts of your body. This information helps establish the stage of your cancer, which describes how advanced it is. Many clinical trials only accept patients with specific stages of disease. For instance, some trials focus on early-stage cancer that hasn’t spread, while others test treatments for advanced cancer that has metastasized.^[1]

Blood tests are also standard for clinical trial screening. These tests check your blood cell counts, liver function, kidney function, and sometimes specific biomarkers. Trials often exclude patients with certain medical conditions that could increase their risk of side effects from the experimental treatment. For example, if a trial drug might affect the liver, you might not qualify if your liver function tests are abnormal.^[1]

Some newer clinical trials focus on precision medicine or targeted therapy, where treatments are designed to work on cancers with specific genetic mutations or molecular characteristics. To qualify for these trials, you may need specialized genetic testing of your tumor through a process called molecular profiling or biomarker testing. This involves analyzing your cancer cells for specific gene mutations, protein levels, or other molecular features that the experimental drug targets. These tests help match patients to the treatments most likely to help them.^[1]

Before the trial begins, you’ll also undergo baseline testing—a complete set of diagnostic tests that establish your starting point. These same tests are often repeated during and after the trial to monitor how well the treatment is working and to watch for any side effects. This careful monitoring is an essential part of clinical research and helps ensure participant safety while gathering data about the experimental treatment’s effectiveness.^[1]